1. Home
  2. ATRO vs EOLS Comparison

ATRO vs EOLS Comparison

Compare ATRO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRO
  • EOLS
  • Stock Information
  • Founded
  • ATRO 1968
  • EOLS 2012
  • Country
  • ATRO United States
  • EOLS United States
  • Employees
  • ATRO N/A
  • EOLS N/A
  • Industry
  • ATRO Military/Government/Technical
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATRO Industrials
  • EOLS Health Care
  • Exchange
  • ATRO Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • ATRO 592.4M
  • EOLS 702.2M
  • IPO Year
  • ATRO N/A
  • EOLS 2018
  • Fundamental
  • Price
  • ATRO $20.20
  • EOLS $13.99
  • Analyst Decision
  • ATRO Hold
  • EOLS Strong Buy
  • Analyst Count
  • ATRO 1
  • EOLS 6
  • Target Price
  • ATRO $17.00
  • EOLS $23.80
  • AVG Volume (30 Days)
  • ATRO 270.2K
  • EOLS 824.4K
  • Earning Date
  • ATRO 03-03-2025
  • EOLS 03-04-2025
  • Dividend Yield
  • ATRO N/A
  • EOLS N/A
  • EPS Growth
  • ATRO N/A
  • EOLS N/A
  • EPS
  • ATRO N/A
  • EOLS N/A
  • Revenue
  • ATRO $782,178,000.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • ATRO $15.96
  • EOLS $34.38
  • Revenue Next Year
  • ATRO $6.89
  • EOLS $31.94
  • P/E Ratio
  • ATRO N/A
  • EOLS N/A
  • Revenue Growth
  • ATRO 19.95
  • EOLS 34.42
  • 52 Week Low
  • ATRO $14.13
  • EOLS $9.25
  • 52 Week High
  • ATRO $23.74
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • ATRO 75.80
  • EOLS 54.04
  • Support Level
  • ATRO $18.54
  • EOLS $14.50
  • Resistance Level
  • ATRO $19.03
  • EOLS $15.06
  • Average True Range (ATR)
  • ATRO 0.56
  • EOLS 0.86
  • MACD
  • ATRO 0.07
  • EOLS -0.00
  • Stochastic Oscillator
  • ATRO 97.56
  • EOLS 27.38

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: